Shapiro cuts ribbon on SCHOTT Pharma USA expansion in Lebanon

Listen to this article

Governor Josh Shapiro and Pennsylvania Department of Community and Economic Development (DCED) Secretary Rick Siger celebrated the expansion of SCHOTT Pharma USA‘s Lebanon County facility.

This investment triples SCHOTT’s manufacturing capacity in the United States, retains more than 200 jobs, and strengthens Pennsylvania’s $50 billion life sciences industry while supporting continued growth in pharmaceutical manufacturing within the commonwealth.

“From day one, I’ve worked to grow Pennsylvania’s economy and make our commonwealth the best place to create new jobs and real opportunity,” Shapiro said in a statement. “Nearly two months ago, I sat down with the President of SCHOTT North America at the NFL Draft in Pittsburgh to talk about why Pennsylvania is the best state in the nation for economic development – and today we are celebrating a significant investment in our commonwealth. 

“Pennsylvania is on the rise and thanks to this new, expanded manufacturing facility, our $50 billion life sciences industry is poised for even more growth.” 

Since 2003, SCHOTT’s Lebanon facility has specialized in drug containment solutions and delivery systems for injectable drugs, producing high‑quality core and specialty vials made from FIOLAX borosilicate glass, built to carry and protect life-saving cancer treatments while in transit. 

Pennsylvania’s life sciences sector is valued at nearly $50 billion and employs over 100,000 people across nearly 3,100 companies and research institutions throughout the commonwealth. Over the past five years, Pennsylvania researchers and companies have secured over 10,700 new life sciences patents — the fourth-highest total in the country.  

“SCHOTT Pharma’s expansion will boost our innovation economy and further strengthen the pharmaceutical manufacturing ecosystem here in Pennsylvania,” said Siger. “Under Governor Shapiro’s leadership, we have an established track record of making the Commonwealth more competitive and a better place to do business. Pennsylvania is on the rise because businesses like SCHOTT are thriving here.” 

The focus of SCHOTT Pharma USA, the North American branch of Germany’s SCHOTT Pharma, is on specialty glass, glass-ceramics, and other advanced materials. SCHOTT Pharma generated an estimated $1.1 billion in global revenue in 2025, with two manufacturing facilities in Lebanon and Duryea, supporting more than 350 jobs in Pennsylvania. 

The past year has seen life sciences companies Johnson & Johnson, Eli Lilly, Eurofins Lancaster Laboratories, and B. Braun announce expansions in Pennsylvania and bring new jobs and R&D investments into the commonwealth.